跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIBTAYO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIBTAYO
Authorized
STANDARD
LIBTAYO
regeneron canada company
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4ad0a74fa894a28d
Company
regeneron canada company
Type
Standard
Approval Details
Approval Id
4ad0a74fa894a28d
Drug Approval Canada Name
LIBTAYO
Product Name
LIBTAYO
Status
Marketed
Status Date
2025-04-07
Original Market Date
2019-05-24
Din
02487144
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
10:00.00
Atc Original
L01FF06 CEMIPLIMAB
Atc Name
l 01 ff 06
Aig Number
0161350001
Company Name
regeneron canada company
Company Address
5050 Satellite Drive, Suite 400, Mississauga, Ontario, Canada, L4W 0G1
Active Ingredients
CEMIPLIMAB
350 MG / 7 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4ad0a74fa894a28d
Type
Standard
Back to Health Canada Approvals